[1]
E. Siegfried, “Pooled Results of VP-102 Safety and Efficacy in Phase 3 Trials for Molluscum Contagiosum by Fitzpatrick Skin Type (FST)”, J of Skin, vol. 5, no. 6, p. s91, Nov. 2021.